Page 202 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.2. Trends in prostate cancer incidence rates (per 100,000 unless otherwise stated) (continued)
Author Database Groups 1980-84 1985-89 1990-94 1995-99 2000-04 2005- Statistical Notes
Year 10 analysis
PMID
57
Potosky SEER- White 840 1310 NR Men ≥65 yr
1995 Medicare Black 1137 1848 old
7530782 Age-adjusted (1987) (1991)
(1970 US
standard)
incidence rate
76
Danley LAC/USC White – non 2.7 (2.3, P<0.001 Additional
1995 CSP Hispanic 3.1) (difference information
8580296 Black/African 0.7 (-0.1, between is
American 1.6) racial/ethnic presented
Asian -0.7 (-2.8, groups for the in Figure 1
Percent annual 1.3) linear trend of the
change in age- 0.2 (-0.8, over 1976-88) paper.
adjusted 1.2)
incidence rates (1988)
(95% CI) using
1976 as the
baseline
Tumor
characteristics –
Stage
17
Hankey SEER Localized/regional NA 3.3 (2.4, 18.7 (10.6, -9.8 (-15.5, Annual Additional
1999 4.2) 27.4) -3.9) percentage information
10379964 Distant NA (1973-88) (1988-92) (1992-95) changes is
1.4 (0.5, -1.3 (-4.1, -17.9 calculated presented
Unstaged -15.3 2.3) 1.6) (−20.8, from joinpoint in Figure 3
(−20.1, (1977-86) (1986-92) −14.9) regression of the
Annual -9.3) 17.9 (14.8, (1991-95) (95% CI). paper.
percentage (1973- 21.0) -22.5
change of the 80) (1980-92) (−32.7,
age-standardized −10.8)
(1970 US (1992-95)
standard)
incidence rates

C-19